[{"id":"43e66abd-33b6-4767-ae9e-3bf715bbb15c","acronym":"","url":"https://clinicaltrials.gov/study/NCT03819387","created_at":"2021-01-18T18:52:12.760Z","updated_at":"2024-07-02T16:35:38.360Z","phase":"Phase 1","brief_title":"A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer","source_id_and_acronym":"NCT03819387","lead_sponsor":"Nitto BioPharma, Inc.","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NBF-006"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 44","initiation":"Initiation: 03/18/2019","start_date":" 03/18/2019","primary_txt":" Primary completion: 03/01/2024","primary_completion_date":" 03/01/2024","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2023-08-31"}]